The Minister of Health Orazio Schillaci, according to what we learn, will propose to the Regions the name of Robert Giovanni Nisticò for the position of new president of the Italian Medicines Agency (Aifa), after the resignation of Giorgio Palù which occurred in controversy with the same minister about a month ago .
Nisticò is professor of Pharmacology at the University of Tor Vergata and has a specialization in Psychiatry and Clinical Psychology obtained at the Catholic University of the Sacred Heart.
Son of the politician and pharmacologist Giuseppe Nisticò - president of the Calabria Region from 1995 to 1998 and former senator and European parliamentarian for the Forza Italia list - Robert Giovanni Nisticò was born in London in 1974 and raised in Italy.
Since 2015, Nisticò has been appointed Regulatory Affairs Expert of the Malta Medicines Agency for the 'scientific and regulatory evaluation in the context of centralized and decentralized procedures.
He is Principal Investigator of the Neuropharmacology Laboratory, European Brain Research Institute - Rita-Levi Montalcini Foundation (research activities: synaptic plasticity, learning and memory, Alzheimer's dementia, multiple sclerosis, inflammation, neurodegeneration).
He is involved in the European Innovative Medicines Initiative (IMI), Rome, for the development and implementation of the IMI strategic research agenda, preparation of IMI calls for tenders and IMI communications with national institutions and public and private research groups.
Since 2016 he has been a member of the Committee for Orphan Medicines (Comp) of the European Medicines Agency (EMA) for the scientific and regulatory evaluation of the orphan drug dossier.
Since November 2017 he has been president of the single-cycle Master's Degree Course in Pharmacy - Department of Biology, Tor Vergata University, with teaching activities in General Pharmacology and Toxicology, Neuropsychopharmacology.
He is also the author or co-author of over 130 publications.
He received a Marie Curie IntraEuropean Fellowship (FEI) for Life Sciences in 2002-2003;
in 2003-2004: Marie Curie Reintegration Grant (ERG) for Life Sciences;
in 2012-2015 and 2015-2018 he was Honorary Lecturer at the Faculty of Pharmacy, University of Nottingham, United Kingdom.
He is an inventor and co-inventor of several patents and a member of the American Society for Neuroscience, the Italian Society of Pharmacology and the American Society for Neuroscience.
Reproduction reserved © Copyright ANSA